Nrf2 has a protective role against neuronal and capillary degeneration in retinal ischemia-reperfusion injury

Free Radical Biology and Medicine

Volumn 51, Issue 1, 2011, Pages 216-224

  Wei, Yanhong ^a   Gong, Junsong ^a   Yoshida, Takeshi ^a   Eberhart, Charles G ^a   Xu, Zhenhua ^a   Kombairaju, Ponvijay ^b   Sporn, Michael B ^c   Handa, James T ^a   Duh, Elia J ^a,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b The Johns Hopkins University   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Apoptosis; Capillary degeneration; Cytokines; Inflammation; Ischemia reperfusion; Knockout mice; Nuclear factor erythroid 2 related factor 2; Reactive oxygen species; Retina; Triterpenoids

Indexed keywords

ANTIOXIDANT; BARDOXOLONE METHYL; SUPEROXIDE; TRANSCRIPTION FACTOR NRF2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CELL LOSS; CELL PROTECTION; CONTROLLED STUDY; GENE EXPRESSION; LEUKOCYTE; MICROVASCULATURE; MOUSE; NERVE CELL; NERVE CELL DEGENERATION; NONHUMAN; PRIORITY JOURNAL; RETINA; RETINA CAPILLARY DEGENERATION; RETINA DISEASE; RETINA INJURY; RETINAL ISCHEMIA REPERFUSION INJURY; VITREOUS BODY;

ANIMALS; ANTIOXIDANTS; CAPILLARIES; CYTOPROTECTION; GENE EXPRESSION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; NERVE DEGENERATION; NF-E2-RELATED FACTOR 2; OLEANOLIC ACID; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY; RETINAL VESSELS;

MUS;

EID: 79957954492     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2011.04.026     Document Type: Article

References (41)

1. N.N. Osborne, R.J. Casson, J.P. Wood, G. Chidlow, M. Graham, and J. Melena Retinal ischemia: mechanisms of damage and potential therapeutic strategies Prog. Retin. Eye Res. 23 2004 91 147 (Pubitemid 38180539)
2. J.M. McCord Oxygen-derived free radicals in postischemic tissue injury N. Engl. J. Med. 312 1985 159 163 (Pubitemid 15192863)
3. J.L. Zweier, J.T. Flaherty, and M.L. Weisfeldt Direct measurement of free radical generation following reperfusion of ischemic myocardium Proc. Natl Acad. Sci. U. S. A. 84 1987 1404 1407 (Pubitemid 17027362)
4. R.J. Korthuis, and D.N. Granger Reactive oxygen metabolites, neutrophils, and the pathogenesis of ischemic-tissue/reperfusion Clin. Cardiol. 16 1993 I19 I26
5. M. Hangai, N. Yoshimura, K. Hiroi, M. Mandai, and Y. Honda Inducible nitric oxide synthase in retinal ischemia-reperfusion injury Exp. Eye Res. 63 1996 501 509 (Pubitemid 26420791)
6. A.H. Neufeld, S. Kawai, S. Das, S. Vora, E. Gachie, J.R. Connor, and P.T. Manning Loss of retinal ganglion cells following retinal ischemia: the role of inducible nitric oxide synthase Exp. Eye Res. 75 2002 521 528 (Pubitemid 35435607)
7. L. Zheng, B. Gong, D.A. Hatala, and T.S. Kern Retinal ischemia and reperfusion causes capillary degeneration: similarities to diabetes Invest. Ophthalmol. Vis. Sci. 48 2007 361 367 (Pubitemid 47251425)
8. M.J. Gourdin, B. Bree, and M. De Kock The impact of ischaemia-reperfusion on the blood vessel Eur. J. Anaesthesiol. 26 2009 537 547
9. M.E. Szabo, M.T. Droy-Lefaix, M. Doly, C. Carre, and P. Braquet Ischemia and reperfusion-induced histologic changes in the rat retina. Demonstration of a free radical-mediated mechanism Invest. Ophthalmol. Vis. Sci. 32 1991 1471 1478
10. B. Chen, S. Caballero, S. Seo, M.B. Grant, and A.S. Lewin Delivery of antioxidant enzyme genes to protect against ischemia/reperfusion-induced injury to retinal microvasculature Invest. Ophthalmol. Vis. Sci. 50 2009 5587 5595
11. J.A. Portillo, J. Van Grol, L. Zheng, G. Okenka, K. Gentil, A. Garland, E.C. Carlson, T.S. Kern, and C.S. Subauste CD40 mediates retinal inflammation and neurovascular degeneration J. Immunol. 181 2008 8719 8726
12. S.F. Abcouwer, C.M. Lin, E.B. Wolpert, S. Shanmugam, E.W. Schaefer, W.M. Freeman, A.J. Barber, and D.A. Antonetti Vascular permeability and apoptosis are separable processes in retinal ischemia-reperfusion injury: effects of ischemic preconditioning, bevacizumab and etanercept Invest. Ophthalmol. Vis. Sci. 51 2010 5920 5933
13. T.W. Kensler, N. Wakabayashi, and S. Biswal Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway Annu. Rev. Pharmacol. Toxicol. 47 2007 89 116
14. J.W. Kaspar, S.K. Niture, and A.K. Jaiswal Nrf2:INrf2 (Keap1) signaling in oxidative stress Free Radic. Biol. Med. 47 2009 1304 1309
15. X.L. Chen, and C. Kunsch Induction of cytoprotective genes through Nrf2/antioxidant response element pathway: a new therapeutic approach for the treatment of inflammatory diseases Curr. Pharm. Des. 10 2004 879 891 (Pubitemid 38380066)
16. N. Li, and A.E. Nel Role of the Nrf2-mediated signaling pathway as a negative regulator of inflammation: implications for the impact of particulate pollutants on asthma Antioxid. Redox Signal. 8 2006 88 98 (Pubitemid 43324534)
17. K. Uno, T.W. Prow, I.A. Bhutto, A. Yerrapureddy, D.S. McLeod, M. Yamamoto, S.P. Reddy, and G.A. Lutty Role of Nrf2 in retinal vascular development and the vaso-obliterative phase of oxygen-induced retinopathy Exp. Eye Res. 90 2010 493 500
18. N. Nagai, R.K. Thimmulappa, M. Cano, M. Fujihara, K. Izumi-Nagai, X. Kong, M.B. Sporn, T.W. Kensler, S. Biswal, and J.T. Handa Nrf2 is a critical modulator of the innate immune response in a model of uveitis Free Radic. Biol. Med. 47 2009 300 306
19. K. Itoh, T. Chiba, S. Takahashi, T. Ishii, K. Igarashi, Y. Katoh, T. Oyake, N. Hayashi, K. Satoh, I. Hatayama, M. Yamamoto, and Y. Nabeshima An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements Biochem. Biophys. Res. Commun. 236 1997 313 322 (Pubitemid 27373291)
20. M.S. Yates, M. Tauchi, F. Katsuoka, K.C. Flanders, K.T. Liby, T. Honda, G.W. Gribble, D.A. Johnson, J.A. Johnson, N.C. Burton, T.R. Guilarte, M. Yamamoto, M.B. Sporn, and T.W. Kensler Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes Mol. Cancer Ther. 6 2007 154 162 (Pubitemid 46206678)
21. F.J. Miller Jr., D.D. Gutterman, C.D. Rios, D.D. Heistad, and B.L. Davidson Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis Circ. Res. 82 1998 1298 1305 (Pubitemid 28294749)
22. H. Zhao, J. Joseph, H.M. Fales, E.A. Sokoloski, R.L. Levine, J. Vasquez-Vivar, and B. Kalyanaraman Detection and characterization of the product of hydroethidine and intracellular superoxide by HPLC and limitations of fluorescence Proc. Natl Acad. Sci. U. S. A. 102 2005 5727 5732 (Pubitemid 40559627)
23. Y. Du, C.M. Miller, and T.S. Kern Hyperglycemia increases mitochondrial superoxide in retina and retinal cells Free Radic. Biol. Med. 35 2003 1491 1499 (Pubitemid 37452474)
24. R.A. Gubitosi-Klug, R. Talahalli, Y. Du, J.L. Nadler, and T.S. Kern 5-Lipoxygenase, but not 12/15-lipoxygenase, contributes to degeneration of retinal capillaries in a mouse model of diabetic retinopathy Diabetes 57 2008 1387 1393
25. L. Zheng, C. Szabo, and T.S. Kern Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB Diabetes 53 2004 2960 2967 (Pubitemid 39425922)
26. V.P. Bindokas, J. Jordan, C.C. Lee, and R.J. Miller Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine J. Neurosci. 16 1996 1324 1336 (Pubitemid 26145913)
27. H. Gyllenhammar Lucigenin chemiluminescence in the assessment of neutrophil superoxide production J. Immunol. Methods 97 1987 209 213 (Pubitemid 17026185)
28. K. Liby, T. Hock, M.M. Yore, N. Suh, A.E. Place, R. Risingsong, C.R. Williams, D.B. Royce, T. Honda, Y. Honda, G.W. Gribble, N. Hill-Kapturczak, A. Agarwal, and M.B. Sporn The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling Cancer Res. 65 2005 4789 4798 (Pubitemid 40740817)
29. K.T. Liby, M.M. Yore, and M.B. Sporn Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer Nat. Rev. Cancer 7 2007 357 369 (Pubitemid 46652485)
30. I. Pitha-Rowe, K. Liby, D. Royce, and M. Sporn Synthetic triterpenoids attenuate cytotoxic retinal injury: cross-talk between Nrf2 and PI3K/AKT signaling through inhibition of the lipid phosphatase PTEN Invest. Ophthalmol. Vis. Sci. 50 2009 5339 5347
31. R.K. Thimmulappa, R.J. Fuchs, D. Malhotra, C. Scollick, K. Traore, J.H. Bream, M.A. Trush, K.T. Liby, M.B. Sporn, T.W. Kensler, and S. Biswal Preclinical evaluation of targeting the Nrf2 pathway by triterpenoids (CDDO-Im and CDDO-Me) for protection from LPS-induced inflammatory response and reactive oxygen species in human peripheral blood mononuclear cells and neutrophils Antioxid. Redox Signal. 9 2007 1963 1970 (Pubitemid 47622348)
32. D. Malhotra, R. Thimmulappa, A. Navas-Acien, A. Sandford, M. Elliott, A. Singh, L. Chen, X. Zhuang, J. Hogg, P. Pare, R.M. Tuder, and S. Biswal Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1 Am. J. Respir. Crit. Care Med. 178 2008 592 604
33. T. Ichikawa, J. Li, C.J. Meyer, J.S. Janicki, M. Hannink, and T. Cui Dihydro-CDDO-trifluoroethyl amide (dh404), a novel Nrf2 activator, suppresses oxidative stress in cardiomyocytes PLoS One 4 2009 e8391
34. L. Yang, N.Y. Calingasan, B. Thomas, R.K. Chaturvedi, M. Kiaei, E.J. Wille, K.T. Liby, C. Williams, D. Royce, R. Risingsong, E.S. Musiek, J.D. Morrow, M. Sporn, and M.F. Beal Neuroprotective effects of the triterpenoid, CDDO methyl amide, a potent inducer of Nrf2-mediated transcription PLoS One 4 2009 e5757
35. Y. Koriyama, K. Chiba, M. Yamazaki, H. Suzuki, K. Muramoto, and S. Kato Long-acting genipin derivative protects retinal ganglion cells from oxidative stress models in vitro and in vivo through the Nrf2/antioxidant response element signaling pathway J. Neurochem. 115 2010 79 91
36. M. Tanito, M.P. Agbaga, and R.E. Anderson Upregulation of thioredoxin system via Nrf2-antioxidant responsive element pathway in adaptive-retinal neuroprotection in vivo and in vitro Free Radic. Biol. Med. 42 2007 1838 1850 (Pubitemid 46754760)
37. S.C. Lu Regulation of glutathione synthesis Mol. Aspects Med. 30 2009 42 59
38. A.T. Dinkova-Kostova, P. Talalay, NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector. Arch. Biochem. Biophys. 501:116-123; 2010.
39. S.A. Rushworth, D.J. MacEwan, and M.A. O'Connell Lipopolysaccharide- induced expression of NAD(P)H:quinone oxidoreductase 1 and heme oxygenase-1 protects against excessive inflammatory responses in human monocytes J. Immunol. 181 2008 6730 6737
40. R. Gozzelino, V. Jeney, M.P. Soares, Mechanisms of cell protection by heme oxygenase-1. Annu. Rev. Pharmacol. Toxicol. 50:323-354; 2010.
41. J. Dulak, A. Loboda, and A. Jozkowicz Effect of heme oxygenase-1 on vascular function and disease Curr. Opin. Lipidol. 19 2008 505 512